In vitro insulinomimetric effects of GLP-1 in liver, muscle and fat

Acta Physiologica Scandinavica

Volumn 157, Issue 3, 1996, Pages 359-360

  Valverde, I ^a   Villanueva penacarrillo M L ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

GLP 1; Glucose metabolism; Incretin; Insulin

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCAGON; INSULIN; PEPTIDE FRAGMENT; PROTEIN PRECURSOR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; CONFERENCE PAPER; GLUCOSE METABOLISM; IN VITRO STUDY; INSULIN RELEASE; LIPOGENESIS; LIVER; MUSCLE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; METABOLISM; PHYSIOLOGY; REVIEW;

ADIPOSE TISSUE; ANIMALS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; INSULIN; LIVER; MUSCLES; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS;

EID: 0029898143     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1996.43257000.x     Document Type: Conference Paper

References (11)

1. Alcá;ntara, A.I., Clemente, F., Viñambres, C., Puente, J., Valverde, I. & Villanueva-Penacarrillo, M.L. 1995. GLP-1 (7-36)amide biological effects in the skeletal muscle of non-insulin-dependent diabetic rats. Diabetologia 38 (Suppl. 1), A39.
2. D'Alessio, D.A., Kahn, S.E., Leusner, C. & Ensick, J. 1994. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest 93, 2263-2266.
3. Delgado, E., Luque, M.A., Alcántara, A., Trapote, M.A., Clemente, F., Galera, C., Valverde, I. & VillanuevaPenacarrillo, M.L. 1995. Glucagon-like peptide-1 binding to rat skeletal muscle. Peptides 16, 225-229.
4. Gutniak, M., Orskov, G, Holst, J.J., Ahren, B. & Effendic, S. 1992. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J A Med 326, 1316-1322.
5. Marquez, L., Morales, M., Ĺopez-Delgado, M.I., Puente, J., Villanueva-Peñacarrillo, M.L. & Valverde, I. 1995. Biological effects of GLP-1 (7-36)amide in the liver of diabetic rats. Diabetologia 38 (Suppl. 1), A172.
6. Mérida, E., Delgado, E., Molina, L.M., VillanuevaPenacarrillo, M.L. & Valverde, I. 1993. Presence of glucagon and glucagon-like peptide-1 (7-36)amide receptors in solubilized membranes of human adipose tissue. J Clin Endocriiwl Metab 77, 1654-1657.
7. Oben, J., Morgan, L., Fletcher, J. & Marks, J. 1991. Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1 (7-36)amide, on fatty acid synthesis in explants of rat adipose tissue. J Endocrinol 130, 267-272.
8. Orskov, C. 1992. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 35, 701-711.
9. Perea, A., Vinambres, G, Clemente, F., VillanuevaPeñacarrillo, M.L. & Valverde, I. 1995. GLP-1 (7-36)amide effects on glucose transport and metabolism in rat fat. Diabetologia 38 (Suppl. 1), A170.
10. Ruiz-Grande, G, Alarcón, C., Mérida, E. & Valverde, I. 1992. Lipolytic action of glucagon-like peptides in isolated rat adipocytes. Peptides 13, 13-16.
11. Thorens, B. 1992. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89, 8641-8645.